Clinical Trial Update: Immunotherapy Adjuvant Trial in Patients With Stage I-III Merkel Cell Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 immunotherapy adjuvant trial for stage I-III Merkel cell carcinoma is active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Merkel Cell Carcinoma

Snippet

Sponsor: Melanoma and Skin Cancer Trials Limited | Conditions: Merkel Cell Carcinoma, Merkel Cell Carcinoma, Stage I | Phase 2 | Status: ACTIVE_NOT_RECRUITING